Perspective Therapeutics Inc (AMEX: CATX) is 10.03% higher on its value in year-to-date trading and has touched a low of $2.70 and a high of $19.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CATX stock was last observed hovering at around $3.31 in the last trading session, with the day’s gains setting it 0.2%.
Currently trading at $3.51, the stock is 5.64% and -45.82% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.2 million and changing 6.04% at the moment leaves the stock -70.48% off its SMA200. CATX registered -15.62% loss for a year compared to 6-month loss of -67.26%. The firm has a 50-day simple moving average (SMA 50) of $6.478 and a 200-day simple moving average (SMA200) of $11.89145.
The stock witnessed a -12.25% gain in the last 1 month and extending the period to 3 months gives it a -73.43%, and is 6.69% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.97% over the week and 9.18% over the month.
Distance from 52-week low is 30.00% and -81.57% from its 52-week high.
with sales reaching $257.76k over the same period.The EPS is expected to grow by 53.61% this year, but quarterly earnings will post -5.60% year-over-year. Quarterly sales are estimated to grow 105.26% in year-over-year returns.
Perspective Therapeutics Inc (CATX) Top Institutional Holders
174.0 institutions hold shares in Perspective Therapeutics Inc (CATX), with institutional investors hold 102.37% of the company’s shares. The shares outstanding are 67.56M, and float is at 48.92M with Short Float at 20.26%. Institutions hold 81.43% of the Float.
Perspective Therapeutics Inc (CATX) Insider Activity
The most recent transaction is an insider purchase by HENSON HEIDI, the company’s Director. SEC filings show that HENSON HEIDI bought 25,975 shares of the company’s common stock on Dec 04 ’24 at a price of $3.85 per share for a total of $0.1 million. Following the purchase, the insider now owns 25975.0 shares.
Perspective Therapeutics Inc disclosed in a document filed with the SEC on Dec 04 ’24 that Spoor Johan M. (CEO) bought a total of 8,000 shares of the company’s common stock. The trade occurred on Dec 04 ’24 and was made at $3.77 per share for $30132.0. Following the transaction, the insider now directly holds 36257.0 shares of the CATX stock.
Still, SEC filings show that on Nov 25 ’24, Williamson Robert F III (Director) acquired 6,266 shares at an average price of $3.64 for $22814.0. The insider now directly holds 430,058 shares of Perspective Therapeutics Inc (CATX).
